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Abstract 
This paper investigates a series of dendrons based on the Newkome dendritic scaffold that displays a 
naturally occurring polyamine (spermine) on their surface. These dendrons have previously been 
shown to interact with DNA in a generation dependent manner with the more highly branched 
dendrons exhibiting a strong multivalency effect for the spermine surface groups. In this paper, we 
investigate the ability of these dendrons to transfect DNA into cells (human breast carcinoma cells, 
MDA-MB-231, and murine myoblast cells, C2C12) as determined by the luciferase assay. Although 
the dendrons are unable to transfect DNA in their own right, they are capable of delivering DNA in 
vitro when administered with chloroquine, which assists with escape from endocytic vesicles. The 
cytotoxicity of the dendrons was determined using the XTT assay, and it was shown that the 
dendrons were nontoxic either alone or in the presence of DNA. However, when administered with 
DNA and chloroquine, the most highly branched dendron did exhibit some cytotoxicity. This paper 
elucidates the relationship between in vitro transfection efficiency and toxicity. While transfection 
efficiencies are modest, the low toxicity of the dendrons, both in their own right, and in the presence 
of DNA, provides encouragement that this type of building block, which has a relatively high affinity 
for DNA, will provide a useful starting point for the further synthetic development of more effective 
gene transfection agents.  
Introduction 
 
The introduction of genetic material into cells (gene transfection) (1) has the potential to treat a 
wide variety of diseases such as those that are characterized by a single mutation at a well-defined 
position on the genome, for example muscular dystrophy (2) and cystic fibrosis (3). Gene therapy is 
also being investigated to treat a range of other diseases, including cancer (4) and AIDS (5), with the 
aim being to introduce genetic material into the affected cells and ultimately lead to their 
destruction. The key problem in gene therapy is the delivery of genetic material to the required cells 
within a patient. Ex vivo methods involve the removal, genetic modification, and readministration of 
the patient's cells. The ex vivo approach enables well controlled localized delivery but has a number 
of limitations such as being labor intensive, requiring special production facilities, and only being 
applicable for accessible and robust cells. More interesting, however, is the development of in vivo 
gene therapies, and with this goal in mind, the development of novel vectors for gene delivery 
capable of navigating a series of extra- and intracellular barriers is of crucial importance.  
Vectors fall into two main categories, viral and nonviral (synthetic) vectors. Viruses are naturally 
evolved vectors, in which part of the virus' genome is replaced with therapeutic genetic material (6). 
Although viral vectors are efficient gene delivery systems and have been utilized in the majority of 
clinical trials, there have been a number of problems with their application in human gene therapy, 
including poor targeting to cells, expensive production, and immunogenic and pathogenic responses. 
Nonviral vectors rely on the ability of synthetic systems to bind and condense the genetic material 
effectively (7). Cationic liposomes (8) (normally used in the presence of a helper lipid) are quite 
efficient, even in vivo, and there is good potential for synthetic modification of this class of delivery 
agent. However, they tend to be relatively unstable and toxic and often lack cell-specific targeting 
ability. Cationic polymers (9) are cheap and simple to modify in order to impart desirable properties 
such as degradation under certain conditions and cell-specific targeting.  
In the last 10 years, there has been an explosion of interest in using dendrimers (10) (highly 
branched monodisperse polymers) as vectors. Their transfection ability is comparable to polymers, 
but many of them exhibit reduced toxicity. The commercially available spherical poly(amidoamine) 
(PAMAM) dendrimers have been extensively studied. It has been shown that fractured (i.e., partially 
degraded) PAMAMs can be more effective at gene transfection, potentially as a consequence of 
their greater flexibility and ability to compact DNA (11). PAMAM dendrimers have also been 
synthetically modified in order to improve solubility and cell membrane fusion and reduce toxicity 
(12). Other spherical dendritic polyamine scaffolds have also been investigated as gene delivery 
systems, such as those based on a poly(propyleneimine) (PPI) framework (13). Dendritic l-lysine 
derivatives have been widely exploited (14), and in a number of these cases, dendrons (individual 
dendritic branches) have been used as DNA binding and gene delivery agents, rather than fully 
formed spherical dendrimers. The inherent asymmetry of the dendron structure facilitates simple 
structural modification in a precisely controlled fashion, either at the surface, or at the focal point. 
This is not possible to the same extent with polymers or spherical dendrimers. The typical ‘dendron 
strategy' is to use a branched molecule with a polycationic surface capable of interacting with the 
anionic phosphates on DNA and then subsequently functionalize the focal point with a unit capable 
of either hydrophobic groups which assist the process of membrane fusion (15) or polar groups 
assisting water solubility and biocompatibility (e.g., poly(ethylene glycol), PEG) (12e).  
Spermine, a naturally occurring linear polyamine, is often utilized as the DNA binding portion of 
nondendritic vectors (16). Indeed, some commercially useful vectors (e.g. Transfectam (17), 
Genzyme Lipid #67 (18), and RPR-120535 (19)) incorporate spermine units. Biology itself makes use 
of simple tetraamines, such as spermine, to achieve DNA binding (20). Although spermine is 
significantly better than an isolated amine for binding DNA, however, the interaction is still relatively 
weak and generates a mobile complex. Consequently, spermine struggles to compete with DNA-
bound inorganic cations (21).  
We have recently reported (22) a series of dendrons utilizing the Newkome dendritic scaffold (23) 
which display multiple spermine groups on the dendritic surface (Figure 1). We demonstrated that 
these dendrons bind DNA in a generation dependent manner (i.e., G0 < G1 < G2), with higher 
generation dendrons exhibiting binding strengths which were independent of salt concentration. 
Dendron G2 showed very strong DNA binding, and we could ascribe this to a clear multivalency 
effect. Some multivalent arrays had been previously reported in which multiple spermine groups 
were grafted onto dextran polymers (24). However, we wanted to develop multivalent DNA binders 
with well-defined molecular structures, to enable the construction of structure−activity 
relationships, as well as developing monodisperse systems, with relatively low molecular weights, 
which have a greater chance of being licensed for therapeutic use in the longer term. In this new 
paper, we explore the in vitro transfection efficiency (as determined by luciferase assay) and the 
toxicity (as determined by XTT assay), using human breast carcinoma cells (MDA-MB-231) and 
murine myoblast cells (C2C12). Most importantly, using this approach, we identify the optimum unit 
(G1) which exhibits the greatest potential for future synthetic development as a nonviral vector.  
 
 Figure 1 Polyamines based on spermine investigated in this paper for their transfection potential, 
including dendritic multivalent spermines, G1 and G2.  
 
Materials and Methods 
 
Polyamine Dendrons. The polyamine dendrons with spermine surface groups were synthesized 
using methods previously reported by us and fully characterized; all data were in agreement with 
those previously published (22).  
Cells and Plasmid DNA. The MDA-MB-231 human breast carcinoma cell line was purchased from the 
American Type Culture Collection, and the C2C12 murine myoblast cell line was a gift from Prof. 
Stephen Kaufman (University of Illinois at Urbana Champaign, IL). All cell lines were maintained 
according to their respective ATCC protocols at 37 °C and 5% CO2 but were adapted from fetal 
bovine serum to heat-inactivated horse serum. The 5.3 kilobase pair expression vector, pGL3 
(Promega, Madison, WI), containing the luciferase gene driven by the SV40 promoter and enhancer, 
was grown in DH5α E. Coli (Gibco BRL, Rockville, MD) and purified using a commercial plasmid 
purification kit (Bio-Rad, Hercules, CA). Plasmids were further purified by ethanol precipitation; the 
ratio of absorbances at 260 and 280 nm was 1.8 or greater.  
Gel Retardation Studies. Appropriate amounts of polyamine and DNA plasmid solutions in 150 mM 
NaCl (pH 7.3, 20 mM PIPES as buffer) were added to a further 10 μL of 150 mM NaCl (pH 7.3, 20 mM 
PIPES as buffer) to achieve the desired polyamine/DNA ratio. The resultant complexes were 
incubated at 4 °C for 15 min. Then, 3 μL Blue/Orange 6X loading dye (Promega, Madison, WI) was 
added, and the mixtures were incubated at 4 °C for a further 5 min. After this time, 15 μL was 
electrophoresed on a 0.75% agarose gel (70 V, 1 h). DNA was visualized with ethidium bromide 
staining (Bio-Rad, Hercules, CA). Samples were run in duplicate.  
Dynamic Light Scattering Studies. DNA−polyamine complexes were prepared at room temperature, 
by the titration of polyamine solution into a solution of plasmid DNA (1 μg) in PBS-buffered Millipore 
water (500 μL) to achieve the desired mass ratios. The volume of polyamine solution added to the 
DNA solution did not exceed 5% of the total volume of the solution. Complex size determination was 
performed by dynamic light scattering on a DynaPro-MS800 particle sizer (Protein Solutions, 
Lakewood, NJ), and the data were analyzed with Dynamics v6.3 software (Protein Solutions). 
Complex Formation and Transfection. DNA−polyamine complexes were prepared at room 
temperature in 150 mM NaCl (pH 7.3, 20 mM PIPES as buffer) by addition of 250 μL of polyamine 
solution to an equal volume of 10 μg of plasmid to achieve the desired polyamine/DNA ratio. The 
resultant complexes were incubated at 4 °C for 15 min. Cells were cultured in standard growth 
medium (DMEM supplemented according to ATCC protocols with 10% horse serum and 1% 
penicillin−streptomycin) and plated in 12-well plates at 1 × 105 cells per well 24 h before 
transfection. Immediately before transfection, the growth medium was replaced with serum-free 
medium, and 50 μL of complex (1 μg of plasmid per well) was added to each well (either with or 
without chloroquine at a final concentration of 100 μM). Transfection medium was replaced with 
growth medium 4 h after transfection. Luciferase expression was quantified 20 h later using a 
Promega luciferase assay system (n ≥ 6) according to the manufacturer's protocol. Luciferase activity 
was measured in relative light units (RLU) using a Lumat LB9507 luminometer (Berthold, GMBH, 
Germany) and converted to luciferase concentration by comparison with recombinant luciferase 
standards (Promega). Results were normalized to total cell protein as determined using a Bio-Rad 
protein assay kit.  
Cytotoxicity Determinations. Cytotoxicity was characterized as a decrease in metabolic activity using 
the XTT assay (25). Cells were placed in 96-well plates at an initial density of 5000 cells per well in 
100 μL of growth medium for 24 h, after which time the growth medium was replaced with fresh 
serum-free medium. At this point a solution of:  polyamine alone (5 μg of polyamine per well), 
polyamine/DNA complexes (1 μg of DNA and 5 μg of polyamine per well), or polyamine/DNA 
complexes with chloroquine (effective transfection conditions:  0.2 μg of DNA, 1.0 μg of polyamine 
per well, chloroquine at a final concentration of 100 μM), in 150 mM NaCl (pH 7.3, 20 mM PIPES as 
buffer) was added (volume equal to or less than 10 μL). Cells were incubated for 4 h, and the 
medium was replaced with complete growth medium for 16 h. Fresh XTT (1 mg/mL) and the 
coenzyme Q0 (80 mg/mL) stock were prepared each day in PBS (0.5 μg/μL XTT and 0.04 μg/μL 
coenzyme Q0), and 25 μL aliquots were added to each well. The samples were incubated for a 
further 4 h at 37 °C, and the absorbance was read at 450 nm relative to blank well prepared without 
cells (n = 16).  
 
Results 
 
Gel Retardation Studies. As outlined in the Introduction, we have previously shown the dendrons to 
be capable of binding plasmid DNA and condensing it into well-defined nanoscale particles. The 
formation of these polyplexes can be observed as a reduction of mobility in gel electrophoresis 
(Figure 2). DNA was mixed with increasing amounts of polyamine in order to determine the ability of 
the polyamine to form complexes with the DNA. Both spermine and the G0 model compound failed 
to retard the migration of DNA, even at mass ratios of 1:100 (DNA:polyamine). In contrast, however, 
dendritic spermine derivatives G1 and G2 both effectively retarded the migration of DNA at mass 
ratios of 1:1 (DNA:polyamine) and above. This highlights the cooperativity of the DNA binding 
afforded by using a dendritic scaffold for the placement of multiple spermine groups, as discussed in 
more detail in our previous publication (22).  
 
 Figure 2 Agarose gel electrophoresis of polyamine/DNA complexes. (A) G0 (polyamine:DNA, w:w):  
lane 1, 0:1; lane 2, 6:1; lane 3, 7:1; lane 4, 8:1; lane 5, 9:1; lane 6, 10:1; lane 7, 20:1; lane 8, 30:1; lane 
9, 40:1; lane 10, 50:1; lane 11, 60:1; lane 12, 70:1; lane 13, 80:1; lane 14, 90:1; lane 15, 100:1. (B and 
C) G1 and G2 respectively (polyamine:DNA, w:w):  lane 1, 0:1; lane 2, 0.1:1; lane 3, 0.2:1; lane 4, 
0.3:1; lane 5, 0.4:1; lane 6, 0.5:1; lane 7, 0.6:1; lane 8, 0.7:1; lane 9, 0.8:1; lane 10, 0.9:1; lane 11, 1:1; 
lane 12, 2:1; lane 13, 3:1; lane 14, 4:1; lane 15, 5:1. 
Dynamic Light Scattering Studies. Polyplex size can be a crucial factor for efficient cell uptake, and 
we therefore investigated the effect of charge ratio on complex size. Complexes with 
polyamine/DNA ratios of 0:1 to 40:1 (w/w), typical of transfection experiments, were formed, and 
dynamic light scattering was used to measure complex size. Assuming that spherical aggregates 
were formed (as observed for G1 and G2 with plasmid DNA by transmission electron microscopy 
[TEM] methods), allowed us to calculate approximate diameters for the aggregates. These studies 
were performed with plasmid DNA alone, and in the presence of spermine, G0, G1, and G2. In each 
case, the experiments were performed at different polyamine:DNA mass ratios in order to see the 
effect of molar ratio on the aggregate formed. The data are presented in Figure 3.  
 
 Figure 3 Dynamic light scattering results indicating the polyamine:DNA mass ratio and the 
approximate dimensions (nm) of the aggregate formed in each case. In the absence of polyamine, 
light scattering indicated a diameter of 66 nm. 
In the absence of DNA, a diameter of 66 nm was determined for the DNA. Spermine and G0 had little 
effect on the dimensions of the system − the diameter of the aggregate remained constant at 
around 40−50 nm, irrespective of the ratio of polyamine to DNA employed. This is in agreement with 
previous studies (20a). Dendron G1 formed significantly larger aggregates in the presence of plasmid 
DNA. This was particularly true at higher polyamine:DNA mass ratios, where nanoscale complexes of 
around 100 nm were present in solution. Previous reports have indicated that complexes in this size 
range are efficiently endocytosed during transfection (26). The size of the aggregates formed 
between G2 and plasmid DNA was significantly larger than that formed between G1 and DNA, in 
agreement with the previous TEM studies (22). Once again, on increasing the polyamine:DNA mass 
ratio, the diameter of these complexes increased significantly (to over 200 nm).  
Complex Formation and Transfection. Our groups are interested in the utilization of gene therapy 
for the treatment of cancer (4) and muscular dystrophy (2); hence, we investigated the efficacy of 
the polyamine dendrons in gene delivery to human breast carcinoma cells (MDA-MB-231) and 
murine myoblasts (C2C12). Both cell lines were transfected in vitro with 1 μg of plasmid DNA per 
100 000 cells. In each case, the DNA was complexed with varying amounts of different polyamines. 
Gene transfection efficiency was measured as luciferase enzyme activity and normalized to total cell 
protein. Initially, the dendrons were investigated in their own right to determine their ability to 
transfect DNA into cells and allow expression of luciferase. However, no measurable transfection 
could be observed in any case.  
However, in the presence of chloroquine (at a final concentration of 100 μM) measurable gene 
transfection was observed with some of the spermine derivatives (Figure 4). Chloroquine is widely 
used as a ‘helper molecule' for gene transfection (27). Although the mechanism of action is not fully 
understood, it has been argued that chloroquine is a weak endosomotropic buffer, raising the 
endosomal pH, resulting in an increase in osmolarity and consequent endosome lysis. In this way 
chloroquine assists the escape of transfected DNA from the endosome. The nondendritic molecules 
(i.e., spermine and G0) induced no measurable gene expression over the range of polyamine:DNA 
mass ratios investigated (1:1 and 4:1). However, some transfection and subsequent luciferase 
expression was observed for the dendritic spermine derivatives in combination with chloroquine. At 
low polyamine:DNA mass ratios (1:1 and 4:1), the second generation dendron was significantly 
better at transfection than the first generation analogue. However, at higher polyamine:DNA mass 
ratios (10:1 and 20:1) the transfection efficiency of the second generation dendron was observed to 
decrease sharply. Under equivalent conditions, the transfection efficiency of the first generation 
analogue G1 increased dramatically. Indeed, G1 became more effective at transfection than G2 at 
high polyamine:DNA mass ratios. A similar trend was observed for both cell lines, although the 
transfection into murine myoblasts C2C12 was higher than that for the human breast carcinoma 
cells (MDA-MB-231).  
 
Figure 4 Transfection efficiency of spermine, the nondendritic model (G0), and the dendrons 
displaying spermine on the surface (G1 and G2) in (a) C2C12 and (b) MDA-MB-231 cells. Luciferase 
expression was normalized by total cellular protein, i.e., data are given in RLU/mg of protein. (N = 6, 
error bars represent standard deviation). Transfection is performed in the presence of chloroquine 
(100 μM). 
Cytotoxicity Determination. Polycationic molecules have been reported to damage cell membranes 
as a result of the electrostatic attraction of polycations to the plasma membrane, whereas neutral 
and anionic polymers cause minimal damage to cellular membranes. With this potential drawback of 
polycationic vectors firmly in mind, we assayed the cytotoxicity of our dendrons using an XTT assay 
(25). Human breast carcinoma cells (MDA-MB-231) and murine myoblasts (C2C12) were exposed to 
various conditions (i.e., polyamine, polyamine+DNA, polyamine+DNA+chloroquine) for 4 h, and 
metabolic activity was assayed 20 h later. The results of these studies are collected in Table 1.  
Table 1.  Cytotoxicity of Spermine, the Nondendritic Model (G0), and First (G1) and Second (G2) 
Generation Dendrons, as well as Poly(ethyleneimine) (PEI) in Murine Myoblast C2C12 and Human 
Breast Carcinoma MDA-MB-231 Cellsa 
    metabolic activity (relative to 1.000) 
cell line conditions spermine G0 G1 G2 PEI CQb  
C2C12  no polyamine            0.512  
C2C12  polyamine alone  0.980  1.000  1.070  1.006  0.705    
C2C12  polyamine + DNA  1.659  1.032  1.032  1.015  0.808    
C2C12  polyamine + DNA + chloroquine  0.758  0.968  1.238  0.305      
MDA-MB-231  no polyamine            0.678  
MDA-MB-231  polyamine alone  1.022  1.070  1.003  0.997  0.878    
MDA-MB-231  polyamine + DNA  1.099  1.063  1.011  1.034  0.954    
MDA-MB-231  polyamine + DNA + chloroquine  0.886  0.979  0.988  0.398      
a  Cytotoxicity is reported as the effective metabolic activity, using an XTT assay. In each case, the 
metabolic activity of a blank sample of cells (i.e. untreated by polyamine, DNA, or chloroquine) was 
taken as 1.000 b CQ = chloroquine; concentration = 100 μM. 
No reduction in metabolic activity was observed when the polyamine alone was added at a 
concentration of 1 μg per 1000 cells. The one exception to this was when a polyamine control (25 
kDa poly(ethyleneimine)) was employed, in which case the observed metabolic activity was reduced 
by 30% for the C2C12 cells. This is important as it indicates that our dendrons are significantly less 
cytotoxic than PEI. Similarly, when a combination of polyamine and DNA was added to the cells (0.2 
μg DNA and 1 μg polyamine per 1000 cells), our dendrons (G1 and G2) had no observable 
cytotoxicity. However, once again, the 25 kDa PEI control reduced metabolic activity, this time by 
20% for the C2C12 cells.  
Significant cytotoxicities, however, were observed in the presence of chloroquine, under 
experimental conditions identical to those in which transfection had been performed (i.e., 0.01 μg 
DNA and 0.1 μg polyamine per 1000 cells, and chloroquine at a final concentration of 100 μM). 
Under these conditions, chloroquine and DNA reduced metabolic activity by 50% (even in the 
absence of polyamines). In the presence of chloroquine, DNA, and either spermine, G0, or G1, the 
cells actually exhibited greater metabolic activities than they did in the absence of the polyamine. 
Indeed, in the presence of G0 or G1, the metabolic activity of the cells was effectively normal. 
However, using chloroquine and DNA in the presence of G2 gave rise to a marked reduction in 
metabolic activity (ca. 70% for C2C12 cells). In all cases, the MDA-MB-231 cells were found to be 
more robust, and the polyamines and chloroquine were found to have smaller effects on the 
metabolic activity than they do for C2C12 cells.  
 
Discussion 
 
For effective transfection, plasmid DNA must be effectively bound and condensed under biological 
conditions (i.e., high salt concentrations, relevant pH values). We have previously shown that 
dendritic molecules G1 and G2 can do this very effectively. We previously used ethidium bromide 
displacement assays to determine that the DNA binding strength was very low for the nondendritic 
systems (i.e., spermine and G0) and significantly higher for G1 and G2. Indeed, for G2 the binding of 
DNA was independent of salt concentration. The detailed gel retardation assays reported in this 
paper indicate that condensation of the DNA occurs from polyamine:DNA mass ratios of 1:1 and 
greater for G1 and G2. Our previous TEM studies indicated that the G1:DNA complexes were 
approximately spherical and 100−150 nm in diameter. The G2:DNA complexes, however, were 
significantly larger (ca. 400 nm). In this paper, we have used light scattering methods to provide 
further evidence for the dimensions of the polyplexes formed between polyamines and DNA in 
solution. The results from these studies are in approximate agreement with the dimensions as 
visualized using TEM methods. Assuming the formation of spherical polyplexes, G1 was calculated to 
form a polyplex with a diameter of up to 100 nm, while G2 once again formed larger polyplexes up 
to approximately 210 nm.  
The results from the in vitro tests reported in this paper indicate that the dendrons are ineffective 
transfection agents in their own right. This is clearly not due to an inability to condense the DNA 
effectively, and we postulate that transfection may fail due to an inability of the polyplex to escape 
from endocytic vesicles. This postulate is supported by the observation that in the presence of 
chloroquine the transfection efficiencies improved significantly. Spermine itself is almost completely 
protonated at physiological pH, and it is therefore possible that these constructs have limited 
capacity to act as proton sponges and buffer the endosome (a process associated with endosomal 
escape). Therefore chloroquine is required to enable the escape process. In this way, we propose 
that these dendritic spermine derivatives behave more like polylysine than proton sponge polymers 
such as PEI or PAMAM. One aspect of future work will focus on improving the ability of these 
dendritic constructs to cross cell membranes and escape from endosomes even in the absence of 
chloroquine. It should also be noted that an alternative postulate is that the polyplexes are so 
strongly bound that they are unable to release the DNA once within the cell.  
In the presence of chloroquine, the nondendritic molecules (spermine and G0) are ineffective 
nonviral vectors for DNA. This is presumably because they fail to bind and condense DNA effectively 
(as shown by our previous ethidium bromide displacement assays and the gel electrophoresis 
reported in this paper). Dendron G1 generally improved in its transfection efficiency on increasing 
the polyamine:DNA mass ratio. At low mass ratios, dendron G2 was significantly more effective than 
G1. However, on increasing the mass ratio, the transfection efficiency achieved by G2 was observed 
to drop significantly, and G1 became the more effective transfection agent. We argue that this 
decrease in transfection efficiency observed with G2 is a consequence of its toxicity when 
administered in the presence of chloroquine (Table 1). Dendron G1 on the other hand has no 
significant toxicity in the presence of chloroquine and therefore became more effective than G2 at 
high polyamine:DNA mass ratios. In this way, the results from our toxicity assay support the 
observed delivery results.  
It must be noted here that even in the presence of chloroquine, the transfection efficiencies 
observed are too low for these structures to have clinically significant activity in vivo. In fact, 
transfection efficiencies would need to be improved by several orders of magnitude. The observed 
efficiencies are in line with low molecular weight poly(amidoamine) (PAMAM) dendrimers (11), 
which only form complexes with DNA at high N/P ratios. In general terms, an increase in molecular 
weight for PAMAMs yields a significant increase in transfection efficiency, and the same trend may 
be expected for higher molecular weight analogues of our dendrons. However, it is also possible to 
make other significant structural modifications to the structure of dendrons G1 and G2 which might 
be expected to enhance transfection efficiencies and would avoid the tedious and time-consuming 
syntheses required for higher generation dendritic molecules. Work to generate simple synthetically 
modified versions of our nontoxic dendrons is currently underway.  
 
Conclusions 
 
In summary, this paper has investigated the ability of our new simple dendron structures, 
functionalized on the surface with multiple spermine groups, to act as vectors in gene therapy. It has 
been shown that the dendrons can transfect DNA in the presence of chloroquine (which assists 
membrane permeation). The transfection efficiencies can be understood in terms of both the DNA 
affinities of the dendrons (G2 > G1 > G0) and the fact that G2 shows some toxicity when 
administered in combination with DNA and chloroquine. The development of structure−activity 
relationships in the area of gene transfection is a goal of considerable importance in the field of gene 
therapy (28).  
However, perhaps the most important observation from this study is that the dendrons exhibit 
negligible toxicities, either in their own right, or in the presence of DNA. This is an important first 
step in the development of potential vectors for application in gene therapy. It is also encouraging 
that the dendritic systems can be encouraged to transfect under certain conditions (i.e., addition of 
chloroquine to enable endosomal escape). We therefore believe that these systems have significant 
potential for application as the DNA binding subunit within more complex constructs designed for 
targeted gene therapy. However, this study has made clear that further synthetic modification of the 
basic dendron structure will be required, to enhance the transfection efficiencies of the nontoxic 
dendritic building blocks. Work targeting this goal is currently in progress within our laboratories, 
and we hope to report dendritic vectors for gene therapy applications, with significantly enhanced 
transfection efficiencies, in due course.  
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